/C O R R E C T I O N -- APAC Liver Disease Alliance/

In the news release, APAC LIVER DISEASE ALLIANCE HOSTS "HEP-FREE: ELIMINATING ASIA'S SILENT PUBLIC HEALTH THREAT BY 2030" SUMMIT IN BANGKOK ON 1 OCTOBER 2024, issued 02-Oct-2024 by APAC Liver Disease Alliance over PR Newswire, we are advised by the company that the photo caption, should read "Kamolluk Srisuwankul, Roche, Mihai Irimescu, Roche, Dr. Chatree Jullapetch, MOPH, Dr. Roberta Sarno,APAC Liver Disease Alliance, Dr. Cheewanan Lertpiriyasuwat, MOPH, Dr. Niti Haetanurak,MOPH, Dr. Pisit Tangkijvanich, Chulalongkorn University, Priyank Dubey, Abbott, Susanna Tan, Abbott, Songsangthong Chanidapa, Abbott, Sureeda Phupat, Roche" rather than "Kamolluck Srisuwankul, Roche, Mihai Irimescu, Roche, Dr. Chatree Jullapetch, MOPH, Dr. Roberta Sarno,APAC Liver Disease Alliance, Dr. Cheewanan Lertpiriyasuwat, MOPH, Dr. Niti Haetanurak,MOPH, Dr. Pisit Tangkijvanich, Chulalongkorn University, Priyank Dubey, Abbott, Susanna Tan, Abbott, Songsangthong Chanidapa, Abbott, Sureeda Phupat, Roche" as originally issued inadvertently. The complete, corrected release follows:

APAC LIVER DISEASE ALLIANCE HOSTS "HEP-FREE: ELIMINATING ASIA'S SILENT PUBLIC HEALTH THREAT BY 2030" SUMMIT IN BANGKOK ON 1 OCTOBER 2024

BANGKOK, Oct. 7, 2024 /PRNewswire/ -- The APAC Liver Disease Alliance, in collaboration with Thailand's Department of Disease Control, Ministry of Public Health, kicks off the Alliance's inaugural "Hep-Free: Eliminating Asia's Silent Public Health Threat by 2030" Summit at The Athenee Hotel, Bangkok.

The Summit brings together leading voices from the healthcare industry, academia, non-profit organizations, and patient advocacy groups across the Asia-Pacific region to discuss policy and advocacy efforts to eliminate hepatitis. Discussions center around improving equitable access to diagnosis and treatment, empowering vulnerable populations, and driving collective action towards a hepatitis-free APAC region.

Dr.Opart Karnkawinpong, Permanent Secretary of the Thailand's Ministry of Public Health, is opening the event, along with representatives from the Ministries of Public Health in Thailand Vietnam and Pakistan.

"Viral hepatitis is a silent public health threat that demands collective action to achieve the elimination targets set by the World Health Organization (WHO) and the UN Sustainable Development Goals. Collaboration among stakeholders is essential to make significant progress and ensure that no one is left behind," states Dr. Opart Karnkawinpong.

Hepatitis is liver inflammation caused by infectious viruses or noninfectious agents, leading to health issues that can be fatal. There are five main types of viral hepatitis — A, B, C, D, and E. While all types cause liver disease, they differ in transmission, severity, and prevention. Hepatitis continues to be a major public health challenge in Asia, with over 821,000 deaths reported across Southeast Asia and the Western Pacific in 2022, according to the World Health Organization (WHO). In Thailand alone, over 2.2 million people are living with hepatitis B, while 300,000 to 800,000 are affected by chronic hepatitis C, a major cause of liver cirrhosis and liver cancer. By implementing a hepatitis prevention and control program at the national level, we can significantly reduce the financial burden on the healthcare system, which currently requires an estimated 1.24 million USD for treating chronic HCV infections nationwide according to the Ministry of Public Health.

Closed by Dr. Lalitaya Kongkam, Deputy Secretary-General of Thailand's National Health Security Office, the Summit aims to address these challenges by fostering partnerships between public and private sectors, identifying gaps in current policies, and sharing best practices to enhance regional efforts.

"The Alliance offers a vital platform for dialogue, enabling stakeholders to work together and synchronize their efforts to eliminate viral hepatitis and enhance public health outcomes throughout the region, "adds Roberta Sarno, Director of the APAC Liver Disease Alliance.

The APAC Liver Disease Alliance is committed to fostering regional cooperation in the fight against hepatitis, serving as a neutral platform for discussions, partnerships, and transformative change, and bringing us closer to a future free of hepatitis.

About APAC Liver Disease Alliance

APAC Liver Disease Alliance is a multilateral group that aims to unite all stakeholders on the mission to counter the rising liver disease epidemic in the APAC region. Its strategic partners include the Coalition for Global Hepatitis Elimination, the Hepatitis Fund, the Harvard Medical School Program in Global Primary Care and Social Change, the Yellow Warriors Society Philippines, the International Liver Cancer Movement, and the Global Liver Institute. Supported by Abbott, AstraZeneca, and Roche, the Alliance is committed to its mission to eliminate Asia's silent emergency. Learn more about their mission here.

For media inquiries, please contact:

Roberta Sarno, Director of the APAC Liver Disease Alliance
Email: roberta.sarno@dhealth.consulting

Phat Parkpien, Consultant, APCO
Email: pparkpien@apcoworldwide.com
Tel: +66 (0) 81 858 6376

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

APAC LIVER DISEASE ALLIANCE HOSTS "HEP-FREE: ELIMINATING ASIA'S SILENT PUBLIC HEALTH THREAT BY 2030" SUMMIT IN BANGKOK ON 1 OCTOBER 2024

HONG KONG, Oct. 7, 2024 /PRNewswire/ -- HKBN Group ("HKBN" or the "Group"; SEHK stock code: 1310) is excited to announce the appointment of Dr Denis Yip as President and Group Chief Operating Officer (COO), effective immediately. He will lead the Group's overall operations, driving innovation to benefit HKBN's customers and shareholders.

Dr Yip has over 30 years of worldwide leadership experience across public and private sectors, possessing extensive business management experience and international exposure. During his career, he has worked in Hong Kong, Beijing, Guangzhou, San Francisco, Shanghai and Tokyo, and served various senior positions in multiple large enterprises, such as Global Vice President, General Manager of the Asia Pacific Storage Division of IBM, Global Senior Vice-president and President, Greater China of EMC Corporation, CEO/President and Director of the Digital China Holdings Company and the Fujian Start Group. Dr Yip was appointed as the Commissioner for Belt and Road of the Commerce and Economic Development Bureau and subsequently served as the CEO of the Hong Kong Applied Science & Technology Research Institute (ASTRI).

Dr Yip graduated from the University of California, Berkeley with a bachelor's and a master's degree in Electrical Engineering and Computer Sciences, an MBA from Golden Gate University, and a Doctor of Business Administration from the University of Management and Technology.

William Yeung, HKBN Co-Owner, Executive Vice-chairman and Group CEO, said, "Denis' rich, dynamic background and stellar leadership in innovation are game-changers for us. His capabilities are crucial as we continue to drive for growth and long-term sustainable profitability. I look forward to working closely with him to focus on customer-centric innovation and operational efficiency."

Dr Denis Yip expressed enthusiasm about the new appointment, "I am thrilled to be part of HKBN and eager to collaborate with our exceptional Talents in this hyper-competitive industry. Leveraging my substantial experience in technology innovation, my goal is to make a meaningful impact, spur growth, and spearhead further business growth."

To learn more about Dr Denis Yip, please visit here.

About HKBN Group

Headquartered in Hong Kong with operations spanning across Hong Kong, Macau and mainland China, HKBN Group ("the Group" or "HKBN") is a leading integrated telecommunications and technology services provider. The Group's extensive tri-carrier fibre infrastructure covers over 2.57 million residential homes and more than 8,100 commercial buildings and facilities across Hong Kong, offering comprehensive one-stop Information and Communications Technology ("ICT") solutions and Infinite-play bundles to both individual and enterprise customers. Committed to creating a lasting positive impact to wherever it operates, HKBN embraces a core purpose to "Make our Home a Better Place to Live" and has received a highest possible rating of AAA in MSCI's 2024 ESG Ratings assessment in environment, society and governance. The Group is managed by hundreds of Co-Owners (supervisory and management level Talents in the Group) who invested their savings to buy shares of HKBN Ltd. (SEHK stock code: 1310). For more information about HKBN, please visit https://www.hkbn.net/group/.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

HKBN Appoints Dr Denis Yip as President and Group Chief Operating Officer